Soft capsule for preventing and treating Alzheimer's disease and preparation method of soft capsule

Abstract

The invention relates to a soft capsule for preventing and treating Alzheimer's disease and a preparation method of the soft capsule. The soft capsule is prepared from the following raw materials in parts by weight: 60 to 80 parts of acer truncatum bunge seed oil, 10 to 25 parts of phospholipid, 6 to 8 parts of seville orange flower, 4 to 7 parts of lycium ruthenicum, and pharmaceutical excipients for the soft capsule. According to the capsule, a large amount of acetylcholine can be generated in a body, the content of the acetylcholine in a brain of an Alzheimer's disease patient is increased, and information conduction is enhanced, so as to activate brain cells and improve memory and intelligence level. The capsule contains natural nervonic acid; the nervonic acid is a unique chemical substance which is recognized in the present world and can be used for repairing damaged nerve fibers, and can promote repair and regeneration of the damaged nerve fibers, thereby improving the memory and the intelligence level. Meanwhile, the soft capsule also has the effects of improving the activity of NK cells and enhancing cellular immunity and humoral immunity, thereby improving human immune functions. The seville orange flower has the efficacy of activating Qi and easing middle jiao, and regulating Qi and soothing the liver, thereby relieving depressive symptoms of the Alzheimer's disease patient.

Description

technical field [0001] The invention belongs to the technical field of functional food, and specifically relates to a soft capsule for preventing and treating Alzheimer's disease and a preparation method thereof. Background technique [0002] Alzheimer's disease (AD), commonly known as senile dementia, occurs more frequently in people over the age of 60, and it tends to become younger in recent years. Alzheimer's disease is generally divided into three stages: the first stage is the mild dementia stage, mainly manifested as memory loss, judgment ability decline, and difficulty in dealing with complex problems; the second stage is the moderate dementia stage with severe memory impairment, time, Location, disorientation, can not independently carry out outdoor activities, often have aphasia, apraxia, agnosia, urinary incontinence; the third stage is severe dementia, memory loss, only fragments of memory, unable to take care of themselves, incontinence, and finally Coma, usual...

AI Technical Summary

Problems solved by technology

[0006] For the prevention and treatment of Alzheimer's disease, it is currently recognized by the medical community that Alzheime